Tyrosine Kinase Inhibitors in the Treatment of Chronic-Phase CML: Strategies for Frontline Decision-making

被引：0
作者：
James A. Kennedy
Gabriela Hobbs
机构：
[1] Brigham and Women’s Hospital,Division of Hematology
[2] University Health Network,Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre
[3] Massachusetts General Hospital,undefined
来源：
Current Hematologic Malignancy Reports | 2018年 / 13卷
关键词：
Chronic myeloid leukemia; Tyrosine kinase inhibitors; BCR-ABL; Treatment-free remission;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：202 / 211
页数：9
相关论文
共 974 条
  • [101] Baccarani M(undefined)undefined undefined undefined undefined-undefined
  • [102] Guilhot F(undefined)undefined undefined undefined undefined-undefined
  • [103] Druker BJ(undefined)undefined undefined undefined undefined-undefined
  • [104] Branford S(undefined)undefined undefined undefined undefined-undefined
  • [105] Kim D-W(undefined)undefined undefined undefined undefined-undefined
  • [106] Pane F(undefined)undefined undefined undefined undefined-undefined
  • [107] Pasquini R(undefined)undefined undefined undefined undefined-undefined
  • [108] Goldberg SL(undefined)undefined undefined undefined undefined-undefined
  • [109] Kalaycio M(undefined)undefined undefined undefined undefined-undefined
  • [110] Moiraghi B(undefined)undefined undefined undefined undefined-undefined
6789101112131415